Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
WARNOCK DAVID L | 0001025664 | May-27-2004 | other: See General Remarks and FN 1 |
PUCKETT STEPHEN R | 0001055047 | May-27-2004 | director |
CAMDEN PARTNERS STRATEGIC FUND II A LP | 0001157600 | May-27-2004 | other: See General Remarks and FN 1 |
CAMDEN PARTNERS STRATEGIC II LLC | 0001160267 | May-27-2004 | other: See General Remarks and FN 1 |
FARINHOLT JAMES B JR | 0001186482 | May-27-2004 | director |
PIROTTE JOHN K | 0001208532 | May-27-2004 | director |
CAMDEN PARTNERS STRATEGIC FUND II B LP | 0001211897 | May-27-2004 | other: See General Remarks and FN 1 |
HUGHES DONALD W | 0001211899 | May-27-2004 | other: See General Remarks and FN 1 |
BERKELEY RICHARD M | 0001211905 | May-27-2004 | other: See General Remarks and FN 1 |
JOHNSTON RICHARD M | 0001211913 | May-27-2004 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PHARMANETICS INC
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-05-107201 (34 Act) Size: 12 KB |
May-13-2005 | 05829099 |
8-K | Document | Current report filing Acc-no: 0001193125-05-102426 (34 Act) Size: 143 KB |
May-10-2005 | 05815460 |
PRE 14A | Document | Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001193125-05-073984 (34 Act) Size: 432 KB |
Apr-11-2005 | 05744463 |
8-K | Document | Current report filing Acc-no: 0001193125-05-056337 (34 Act) Size: 11 KB |
Mar-21-2005 | 05693703 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001193125-05-053858 (34 Act) Size: 684 KB |
Mar-17-2005 | 05688307 |
8-K | Document | Current report filing Acc-no: 0001193125-05-051034 (34 Act) Size: 216 KB |
Mar-15-2005 | 05681803 |
8-K | Document | Current report filing Acc-no: 0001193125-04-211853 (34 Act) Size: 11 KB |
Dec-13-2004 | 041198492 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001193125-04-197320 (34 Act) Size: 257 KB |
Nov-15-2004 | 041145381 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001193125-04-141694 ( Act) Size: 258 KB |
Aug-16-2004 | 04978402 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-04-035657 ( Act) Size: 14 KB |
Jul-12-2004 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001181431-04-034843 ( Act) Size: 10 KB |
Jul-12-2004 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001181431-04-034842 ( Act) Size: 12 KB |
Jul-12-2004 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001181431-04-034840 ( Act) Size: 13 KB |
Jul-12-2004 | |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-04-114656 ( Act) Size: 1068 KB |
Jul-07-2004 | 04903583 |
POS AM | Document | Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-04-111144 ( Act) Size: 1170 KB |
Jun-29-2004 | 04888042 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001193125-04-088940 ( Act) Size: 249 KB |
May-14-2004 | 04808872 |
8-K | Document | Current report filing Acc-no: 0001193125-04-081927 ( Act) Size: 15 KB |
May-07-2004 | 04788570 |
8-K | Document | Current report filing Acc-no: 0001193125-04-079204 ( Act) Size: 22 KB |
May-05-2004 | 04781325 |
ARS | Document | Annual report to security holders Acc-no: 9999999997-04-021299 ( Act) Size: 1 KB |
May-04-2004 | 04028234 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0001193125-04-072475 ( Act) Size: 304 KB |
Apr-29-2004 | 04761907 |
Recent 20 filings. View all PHARMANETICS INC filings
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by